TRIB
Trinity Biotech
TRIB
TRIB
81 hedge funds and large institutions have $325M invested in Trinity Biotech in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
54% less call options, than puts
Call options by funds: $356K | Put options by funds: $781K
Holders
81
Holding in Top 10
3
Calls
$356K
Puts
$781K
Top Buyers
| 1 | +$10.5M | |
| 2 | +$6.93M | |
| 3 | +$5.44M | |
| 4 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$4.08M |
| 5 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$3.56M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$3.24M | |
| 3 | -$1.15M | |
| 4 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$1.09M |
| 5 |
RA
Royce & Associates
New York
|
-$1.04M |